share_log

Lifeist Wellness Inc. (OTCMKTS:NXTTF) Sees Large Growth in Short Interest

kopsource ·  Oct 1, 2022 16:22

Lifeist Wellness Inc. (OTCMKTS:NXTTF – Get Rating) saw a large increase in short interest in September. As of September 15th, there was short interest totalling 647,800 shares, an increase of 27.9% from the August 31st total of 506,300 shares. Based on an average daily volume of 1,642,500 shares, the short-interest ratio is currently 0.4 days.

Lifeist Wellness Stock Performance

Shares of OTCMKTS:NXTTF traded up $0.01 during trading hours on Friday, hitting $0.06. 50,358 shares of the company's stock traded hands, compared to its average volume of 232,573. Lifeist Wellness has a 52 week low of $0.03 and a 52 week high of $0.11. The company's fifty day simple moving average is $0.05 and its two-hundred day simple moving average is $0.05.

Get Lifeist Wellness alerts:

Lifeist Wellness Company Profile

(Get Rating)

Lifeist Wellness Inc operates as a wellness company in the United States and Canada. The company operates CannMart.com, an online marketplace for hemp-derived CBD and accessories; and Findify, an artificial intelligence powered technology platform that offers personalized search, recommendations, and advanced data analytics for B2B ecommerce customers, as well as a butane hash oil extraction facility.

Further Reading

  • Get a free copy of the StockNews.com research report on Lifeist Wellness (NXTTF)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Let Paychex Stock Work Hard For You
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?

Receive News & Ratings for Lifeist Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeist Wellness and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment